PharmChem, Inc. (PCHM)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.76 Million USD | -32.25% |
| 2022 | 4.08 Million USD | 20.38% |
| 2021 | 3.39 Million USD | -60.8% |
| 2020 | 8.65 Million USD | 25.03% |
| 2019 | 6.91 Million USD | 18.03% |
| 2018 | 5.86 Million USD | 28.34% |
| 2017 | 4.56 Million USD | 26.43% |
| 2016 | 3.61 Million USD | 0.0% |
| 2002 | 22.66 Million USD | -20.46% |
| 2001 | 28.49 Million USD | 4.52% |
| 2000 | 27.26 Million USD | 8.86% |
| 1999 | 25.04 Million USD | 13.52% |
| 1998 | 22.06 Million USD | -0.15% |
| 1997 | 22.09 Million USD | 2.93% |
| 1996 | 21.46 Million USD | -3.3% |
| 1995 | 22.2 Million USD | -21.55% |
| 1994 | 28.3 Million USD | -2.41% |
| 1993 | 29 Million USD | -7.94% |
| 1992 | 31.5 Million USD | 16.24% |
| 1991 | 27.1 Million USD | 141.96% |
| 1990 | 11.2 Million USD | 16.67% |
| 1989 | 9.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.95 Million USD | 6.78% |
| 2024 Q2 | 3.38 Million USD | 14.6% |
| 2023 FY | 2.76 Million USD | -32.25% |
| 2023 Q1 | 2.9 Million USD | -28.72% |
| 2023 Q2 | 3.15 Million USD | 8.44% |
| 2023 Q3 | 3.25 Million USD | 3.05% |
| 2023 Q4 | 2.76 Million USD | -14.95% |
| 2022 FY | 4.08 Million USD | 20.38% |
| 2022 Q2 | 3.57 Million USD | -0.25% |
| 2022 Q4 | 4.08 Million USD | 7.34% |
| 2022 Q1 | 3.58 Million USD | 5.75% |
| 2022 Q3 | 3.8 Million USD | 6.32% |
| 2021 Q2 | 8.34 Million USD | 0.0% |
| 2021 Q4 | 3.39 Million USD | -41.39% |
| 2021 FY | 3.39 Million USD | -60.8% |
| 2021 Q3 | 5.78 Million USD | -30.67% |
| 2020 FY | 8.65 Million USD | 25.03% |
| 2019 FY | 6.91 Million USD | 18.03% |
| 2018 FY | 5.86 Million USD | 28.34% |
| 2017 FY | 4.56 Million USD | 26.43% |
| 2016 FY | 3.61 Million USD | 0.0% |
| 2003 Q1 | 20.82 Million USD | -8.11% |
| 2003 Q2 | 19.85 Million USD | -4.7% |
| 2003 Q3 | 18.45 Million USD | -7.02% |
| 2002 Q4 | 22.66 Million USD | -4.44% |
| 2002 Q1 | 28.22 Million USD | -0.96% |
| 2002 FY | 22.66 Million USD | -20.46% |
| 2002 Q2 | 25.32 Million USD | -10.27% |
| 2002 Q3 | 23.72 Million USD | -6.33% |
| 2001 FY | 28.49 Million USD | 4.52% |
| 2001 Q2 | 27.42 Million USD | -0.13% |
| 2001 Q3 | 29.66 Million USD | 8.14% |
| 2001 Q4 | 28.49 Million USD | -3.92% |
| 2001 Q1 | 27.46 Million USD | 0.73% |
| 2000 Q2 | 26.35 Million USD | 3.56% |
| 2000 Q4 | 27.26 Million USD | 1.85% |
| 2000 FY | 27.26 Million USD | 8.86% |
| 2000 Q1 | 25.45 Million USD | 1.62% |
| 2000 Q3 | 26.77 Million USD | 1.57% |
| 1999 Q3 | 24.8 Million USD | 5.08% |
| 1999 FY | 25.04 Million USD | 13.52% |
| 1999 Q4 | 25.04 Million USD | 0.99% |
| 1999 Q2 | 23.6 Million USD | 4.89% |
| 1999 Q1 | 22.5 Million USD | 1.98% |
| 1998 Q4 | 22.06 Million USD | -4.49% |
| 1998 FY | 22.06 Million USD | -0.15% |
| 1998 Q3 | 23.1 Million USD | -2.53% |
| 1998 Q2 | 23.7 Million USD | 8.22% |
| 1998 Q1 | 21.9 Million USD | -0.89% |
| 1997 Q3 | 22.2 Million USD | 1.37% |
| 1997 Q1 | 20.3 Million USD | -5.44% |
| 1997 FY | 22.09 Million USD | 2.93% |
| 1997 Q2 | 21.9 Million USD | 7.88% |
| 1997 Q4 | 22.09 Million USD | -0.47% |
| 1996 FY | 21.46 Million USD | -3.3% |
| 1996 Q2 | 22.8 Million USD | 0.44% |
| 1996 Q4 | 21.46 Million USD | -1.97% |
| 1996 Q3 | 21.9 Million USD | -3.95% |
| 1996 Q1 | 22.7 Million USD | 2.25% |
| 1995 FY | 22.2 Million USD | -21.55% |
| 1995 Q4 | 22.2 Million USD | -28.16% |
| 1995 Q1 | 28.3 Million USD | 0.0% |
| 1995 Q3 | 30.9 Million USD | 0.0% |
| 1994 Q4 | 28.3 Million USD | 1.8% |
| 1994 Q3 | 27.8 Million USD | 0.0% |
| 1994 Q1 | 28.8 Million USD | -0.69% |
| 1994 FY | 28.3 Million USD | -2.41% |
| 1993 FY | 29 Million USD | -7.94% |
| 1993 Q2 | 30.7 Million USD | 0.0% |
| 1993 Q3 | 26.6 Million USD | -13.36% |
| 1993 Q4 | 29 Million USD | 9.02% |
| 1992 Q4 | 31.5 Million USD | 0.0% |
| 1992 FY | 31.5 Million USD | 16.24% |
| 1991 FY | 27.1 Million USD | 141.96% |
| 1991 Q4 | 27.1 Million USD | 0.0% |
| 1990 Q4 | 11.2 Million USD | 0.0% |
| 1990 FY | 11.2 Million USD | 16.67% |
| 1989 FY | 9.6 Million USD | 0.0% |
| 1989 Q4 | 9.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -117.932% |
| Arrayit Corporation | 1 Million USD | -176.448% |
| Atlantic International Corp. | 4.43 Million USD | 37.662% |
| Biocept, Inc. | 30.87 Million USD | 91.042% |
| Bioqual, Inc. | 56.58 Million USD | 95.113% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -1092.401% |
| DermTech, Inc. | 121.93 Million USD | 97.732% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.934% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 84.444% |
| iMD Companies, Inc. | 190.13 Thousand USD | -1354.509% |
| IDenta Corp. | 1.52 Million USD | -80.841% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 78.761% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 66.486% |
| InVitro International | 1.53 Million USD | -80.283% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 89.695% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -119517.604% |
| Medical Imaging Corp. | 4.19 Million USD | 34.022% |
| NovelStem International Corp. | 2.25 Million USD | -22.666% |
| Optigenex Inc. | 1.88 Million USD | -46.458% |
| Proteome Sciences plc | 14.58 Million USD | 81.04% |
| Response Genetics, Inc | 48.88 Million USD | 94.343% |
| Rennova Health, Inc. | 20.57 Million USD | 86.557% |
| RushNet, Inc. | 6.04 Million USD | 54.27% |
| ScreenPro Security Inc. | 1.26 Million USD | -119.252% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -485.399% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -294.712% |
| Todos Medical Ltd. | 15.26 Million USD | 81.885% |